Status:

COMPLETED

Symptomatic Treatment of Acute Uncomplicated Diverticulitis

Lead Sponsor:

Helsinki University Central Hospital

Collaborating Sponsors:

Vatsatautien tutkimussäätiö - foundation

Mary and Georg Ehrnroot's foundation

Conditions:

Diverticulitis

Eligibility:

All Genders

18-90 years

Phase:

NA

Brief Summary

The purpose of this study is to determine the safety and efficacy of symptomatic treatment (i.e. without antimicrobial drugs) of acute uncomplicated diverticulitis.

Eligibility Criteria

Inclusion

  • Computed tomography-diagnosed acute uncomplicated\* diverticulitis
  • No abscess, fistula, obstruction and distant intra- or retroperitoneal air. Pericolic air allowed.

Exclusion

  • Already commenced antimicrobial medication
  • Immunosuppression (e.g. diabetes, corticosteroid medication, immunosuppressive medication, chemotherapy, chronic liver disease)
  • Suspicion of generalized peritonitis
  • Organ dysfunction
  • Another infection requiring antimicrobial medication
  • Pregnancy
  • Age \< 18 years or \> 90 years
  • Missing written consent

Key Trial Info

Start Date :

July 1 2014

Trial Type :

INTERVENTIONAL

Allocation :

ESTIMATED

End Date :

Estimated Enrollment :

158 Patients enrolled

Trial Details

Trial ID

NCT02219698

Start Date

July 1 2014

Last Update

July 31 2015

Active Locations (1)

Enter a location and click search to find clinical trials sorted by distance.

Page 1 of 1 (1 locations)

1

Helsinki University Central Hospital

Helsinki, Finland, 00029

Symptomatic Treatment of Acute Uncomplicated Diverticulitis | DecenTrialz